2026 Global Initiative for Chronic Obstructive Lung Disease (GOLD) International Chronic Obstructive Pulmonary Disease (COPD) Conference

2026 Global Initiative for Chronic Obstructive Lung Disease (GOLD) International Chronic Obstructive Pulmonary Disease (COPD) Conference is organized by Integrity Continuing Education Inc. and will be held from Nov 05 - 06, 2026 at Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States of America.

Description:
This year’s conference will once again feature an impactful lineup of speakers, panels, and sessions covering the latest advances in COPD management and care. Hear directly from the experts, and gain insights you can bring back and apply immediately to improve outcomes for your patients.

This conference will be presented in a hybrid format with in-person sessions simulcast to a global audience of healthcare providers involved in the care and management of people with COPD.

Learning Objectives:
Upon completion of the following educational activities, participants will be able to:

Pre-Conference Sessions - COPD Essentials: Translating the GOLD Strategy Into Practice

Session #1 - From Diagnosis to Initial Treatment: Applying the GOLD Strategy in Everyday COPD Care

• Apply the Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy to diagnose COPD and select initial pharmacologic therapy based on ABE classification and patient risk

Session #2 - Inhaler & Device Selection in COPD Management

• Analyze patient characteristics and inhaler device attributes to select appropriate inhaler or nebulized therapy

Session #3 - Respiratory Therapy–Led Strategies to Improve Outcomes in COPD

• Integrate respiratory therapy–led and nonpharmacologic interventions, including pulmonary rehabilitation and supportive respiratory therapies, into COPD management

Session #4 - Advancing Therapy in COPD: What’s After Maximized Inhaler Therapy?

• Assess disease control and identify indicators of inadequate response to current COPD therapy
• Escalate COPD treatment using phenotype-driven approaches to address persistent dyspnea and exacerbation risk

2026 GOLD International COPD Conference Sessions

Session #1: Role of Mucus in Disease Progression in COPD

• Describe the clinical burden of mucus plugging in patients with moderate to severe COPD
• Explain the role of type 2 cytokines in mucus plug formation and airway obstruction

Session #2: Characterizing Exacerbations in COPD

• Describe the clinical features used to define COPD exacerbations
• Discuss how to evaluate the Rome proposal framework for classifying COPD exacerbations
• Identify appropriate diagnostic testing for patients presenting with acute worsening of dyspnea

Session #3: Multimorbidity in Patients With COPD: What Can We Do About It?

• Describe the 5 M’s framework for managing complex COPD populations
• Identify common cardiovascular comorbidities associated with COPD

Session #4: Moving to a Proactive Approach to the Diagnosis, Assessment and Management of COPD

• Recognize factors contributing to the underdiagnosis of COPD
• Identify strategies to detect COPD in community populations
• Define disease stability in patients with COPD

Session #5: Targeting Neutrophilic Inflammation in COPD

• Describe the role of neutrophilic inflammation in COPD pathophysiology
• Explain therapeutic approaches targeting neutrophil activity in COPD

Session #6: 2027 GOLD Report and Review

• Summarize key updates in the 2027 GOLD Report
• Describe implications of GOLD recommendations for COPD management

Session #7: Targeting Pathways in COPD: A Glimpse Into the Future?

• Describe emerging biologic targets in COPD airway immunology
• Explain the role of epithelial alarmins in COPD inflammation